Compounds > 5-methylurapidil
Page last updated: 2024-08-16

5-methylurapidil and piperidines

5-methylurapidil has been researched along with piperidines in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bigg, DC; Koek, W; Sleight, AJ1
Farias-Rodríguez, VM; Gallardo-Ortíz, IA; Gómez-Zamudio, JH; Lázaro-Suárez, ML; Tanoue, A; Tsujimoto, G; Villalobos-Molina, R1
Asbun-Bojalil, J; Castillo-Henkel, C; Castillo-Hernández, MC; Cervantes-Cruz, J; Cruz-Domínguez, MP; Miliar-García, A; Montes-Cortés, DH; Reséndiz-Ramírez, AC; Villalobos-Molina, R1

Other Studies

3 other study(ies) available for 5-methylurapidil and piperidines

ArticleYear
Binding of antipsychotic drugs at alpha 1A- and alpha 1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors.
    European journal of pharmacology, 1993, Jul-20, Volume: 238, Issue:2-3

    Topics: Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Binding Sites; Dioxanes; Hippocampus; In Vitro Techniques; Isoxazoles; Male; Phentolamine; Piperazines; Piperidines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Risperidone; Spleen

1993
Chloroethylclonidine reveals that alpha (1 A)-adrenoceptors mediate contraction in aorta of alpha (1 D)-adrenoceptor knockout mice.
    Autonomic & autacoid pharmacology, 2005, Volume: 25, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta; Clonidine; Dose-Response Relationship, Drug; Imines; In Vitro Techniques; Mice; Mice, Knockout; Norepinephrine; Piperazines; Piperidines; Receptors, Adrenergic, alpha-1; Vasoconstriction; Vasoconstrictor Agents

2005
Evidence of alpha1-adrenoceptor functional changes in omental arteries of patients with end-stage renal disease.
    Autonomic & autacoid pharmacology, 2008, Volume: 28, Issue:1

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Arteries; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Imines; Kidney Failure, Chronic; Male; Middle Aged; Omentum; Phenylephrine; Piperazines; Piperidines; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasoconstriction; Vasoconstrictor Agents

2008